Christian Jones

Christian Jones

BakerHostetler

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › Pharmaceutical Industry

Share:

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: shutdown risk increases as talks stall; Gottlieb’s Hill testimony postponed; more bills...more

2/12/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicaid , Medicare Part D , Opioid , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more

2/5/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Preexisting Conditions , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug...more

1/29/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves Medicaid measures, and more....more

1/23/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicaid , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more....more

1/14/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Tax Deductions

Capitol Hill Healthcare Update

Highlights this week: how the partial government shutdown is affecting operations at the FDA; House Democrats take steps to defend the ACA; the House votes this week to renew emergency health response programs; new senators...more

1/8/2019  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Highlights this week include a lame duck update on year-end health bills and tax provisions; lawmakers reacting to a federal judge ruling the Affordable Care Act is unconstitutional; Sen. Hatch seeks to update Hatch-Waxman;...more

12/17/2018  /  Affordable Care Act , Congressional Budget Office , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Furloughs , Government Shutdown , Medicare Part D , Patents , Pharmaceutical Industry , Trump Administration , USPTO

Capitol Hill Healthcare Update

Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key...more

12/4/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Democrats’ takeover of the House will yield big changes for healthcare policy in 2019; several GOP lawmakers active in healthcare policy are defeated; pharma pushes for Part D changes in the lame duck;...more

11/13/2018  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Lame Duck Session , Medical Devices , Medicare , Medicare Part A , Medicare Part D , Pharmaceutical Industry , Prescription Drug Coverage

Congress Agrees to Final Opioids Bill With Vote Scheduled This Week

House and Senate leaders Wednesday agreed to sweeping new legislation to respond to the national opioid epidemic, including authorizing $8 billion in grant programs for states, expanding access to prevention and treatment,...more

9/26/2018  /  Opioid , Pharmaceutical Industry , Prescription Drugs , Proposed Legislation , Substance Abuse , Trump Administration

Capitol Hill Healthcare Update

Included this week is an update on congressional efforts to finish opioids response legislation; efforts by pharmaceutical manufacturers to change discounts they are required to provide Medicare beneficiaries in the Part D...more

9/25/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Prescription Drugs

Senate OKs Opioids Response Bill as Lawmakers Scramble to Pass Final Measure

The Senate this week overwhelmingly approved legislation to address the opioid crisis, and now Congress is racing to cobble together a final measure that could pass before the midterm elections in November....more

9/21/2018  /  Health Care Providers , Opioid , Pharmaceutical Industry , Prescription Drugs , Substance Abuse

Capitol Hill Healthcare Update

Featured in this week’s Update, the Senate votes on September 17, 2018 on opioids legislation (the House is not in session this week); Congress reaches an agreement on fiscal 2019 healthcare funding; the pharma industry last...more

9/18/2018  /  Department of Health and Human Services (HHS) , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on a pending Senate vote on opioid legislation as Congress races to enact a response to the crisis before the November election; the Senate votes to expand...more

9/11/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Disclosure Requirements , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on Congress reconvening after a summer break and facing near-term deadlines on government funding, including for healthcare agencies and programs; whether...more

9/5/2018  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Opioid , Pharmaceutical Industry , Pharmacies , Popular , Prescription Drugs , Section 340B , Trump Administration

Capitol Hill Healthcare Update

HOUSE OKs DOZENS OF OPIOID-RELATED BILLS; MORE VOTES SCHEDULED - The House last week approved 38 bills that lawmakers hope will stem the opioid epidemic, and it scheduled votes this week on at least a dozen more....more

6/19/2018  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , GAO , Generic Drugs , Health Care Providers , Healthcare Fraud , HRSA , Medicaid , National Institute of Health (NIH) , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Section 340B

Capitol Hill Healthcare Update

HOUSE TO VOTE ON DOZENS OF OPIOID BILLS WHILE SENATE READIES COMPREHENSIVE MEASURE - The House this week will begin considering some of the 70 different opioid bills that have been approved by eight different committees,...more

6/12/2018  /  Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , HRSA , Opioid , Pharmaceutical Industry , Prescription Drugs , Section 340B , Trump Administration

Capitol Hill Healthcare Update

RYAN SAYS POTENTIAL COMPROMISE COMING ON RISK EVALUATION AND MITIGATION STRATEGY DRUGS - House Speaker Paul Ryan, R-Wis., last week said congressional leaders are trying to hammer out compromise legislation that would make it...more

5/22/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Department of Veterans Affairs , Drug Pricing , Food and Drug Administration (FDA) , HELP , Opioid , Pharmaceutical Industry , Prescription Drugs , REMS , Right to Try

Capitol Hill Healthcare Update

LAWMAKERS PRAISE, CRITICIZE TRUMP PLAN ON DRUG PRICES - On Capitol Hill, reaction to President Donald Trump’s “American Patients First” plan to bring down prescription drug prices fell predictably along partisan lines:...more

5/15/2018  /  Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Opioid , Pharmaceutical Industry , Prescription Drugs , Section 340B , Trump Administration

Capitol Hill Healthcare Update

GOP LAWMAKERS: EUROPE, CANADA ‘FREE RIDING’ ON US DRUG INNOVATION - More than two dozen House Republicans last week called on President Donald Trump to leverage upcoming trade negotiations to stop other nations from “free...more

5/8/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medical Marijuana , Medicare , Medicare Advantage , Opioid , Pharmaceutical Industry , Prescription Drugs , Section 340B , Trump Administration

Capitol Hill Healthcare Update

AZAR ILLNESS DELAYS WHITE HOUSE ANNOUNCEMENT ON DRUG PRICING INITIATIVE - Health & Human Services (HHS) Secretary Alex Azar is recovering at his home in Indianapolis following his second hospitalization in less than a week...more

4/24/2018  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Generic Drugs , Medicare , Opioid , Pharmaceutical Industry , Physicians , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

HOUSE VOTE SET FOR UPDATED ‘RIGHT-TO-TRY’ LEGISLATION - The House will vote Tuesday on updated but still controversial legislation that would give terminally ill patients wider access to prescription drugs that haven’t won...more

3/13/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare Part D , Patient Access , Pharmaceutical Industry , Prescription Drugs , Right to Try , Section 340B

Capitol Hill Healthcare Update

The year-end schedules of the Senate HELP and Finance committees just became more clogged, as the two panels will lead the review of President Trump’s nominee to be Health & Human Services (HHS) secretary. Trump announced...more

11/14/2017  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Individual Mandate , Pharmaceutical Industry , Tax Credits , Telehealth

Capitol Hill Healthcare Update

President Donald Trump is considering appointing lawmakers to a bipartisan commission that would develop strategies to lower prescription drug prices, while senators last week called for greater transparency into how...more

10/24/2017  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Generic Drugs , Health Care Providers , Medicare , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Congressional Republicans and President Donald Trump face a series of key questions about how or whether to fortify the Affordable Care Act – particularly in the law’s beleaguered individual exchanges – after the Senate last...more

8/1/2017  /  510(k) RTA , Affordable Care Act , Cybersecurity , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Medical Devices , Medicare , Opioid , Pharmaceutical Industry , Trump Administration
54 Results
 / 
View per page
« Previous
Page: of 3
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide